Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
| Status: | Recruiting |
|---|---|
| Conditions: | Other Indications, Infectious Disease, Urology, Urinary Tract Infections |
| Therapuetic Areas: | Immunology / Infectious Diseases, Nephrology / Urology, Other |
| Healthy: | No |
| Age Range: | 18 - 89 |
| Updated: | 5/9/2018 |
| Start Date: | October 10, 2017 |
| End Date: | December 31, 2019 |
| Contact: | Dina Flink, PhD |
| Email: | dina.flink@ucdenver.edu |
| Phone: | 303-724-8467 |
Urinary Tract Infection (UTI) complications following catheter use in surgical patients
remains high. Using an aseptic protocol has been shown to drastically reduce UTI incidence by
50%. Reducing UTIs will prevent extended hospital stays, readmission, and antibiotic use
associated with this complication and improve cost-effectiveness of care. The investigators
hypothesize that they can reduce the incidence of UTIs after catheter placement with the
implementation of a Quality Improvement (QI) protocol to prevent excess exposure to the
environment exposure of the catheter before, during and after insertion.
remains high. Using an aseptic protocol has been shown to drastically reduce UTI incidence by
50%. Reducing UTIs will prevent extended hospital stays, readmission, and antibiotic use
associated with this complication and improve cost-effectiveness of care. The investigators
hypothesize that they can reduce the incidence of UTIs after catheter placement with the
implementation of a Quality Improvement (QI) protocol to prevent excess exposure to the
environment exposure of the catheter before, during and after insertion.
Inclusion Criteria:
1. women 18-89 years of age
2. admitted for surgery lasting >1 hour and requiring urinary catheter,
3. have normal urine analysis within 24 hours pre-surgery, and
4. able to provide informed consent.
Exclusion Criteria:
1. currently on dialysis,
2. chronic urinary infection,
3. hyperthyroidism,
4. current infection,
5. a history of allergy or sensitivity to iodine.
6. women who are pregnant or breast feeding
7. men due to their lower incidence of UTIs compared to the female population.
We found this trial at
1
site
13001 E. 17th Pl
Aurora, Colorado 80045
Aurora, Colorado 80045
303-724-5000
Principal Investigator: Saketh Guntupalli, MD
Phone: 303-724-8467
University of Colorado Denver The University of Colorado Denver | Anschutz Medical Campus provides a...
Click here to add this to my saved trials
